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Abstract
In this paper, we perform a complete analysis of the kinetic behavior of the gen-
eral modifier mechanism of Botts and Morales in both equilibrium steady states and
non-equilibrium steady states (NESS). Enlightened by the non-equilibrium theory
of Markov chains, we introduce the net flux into discussion and acquire an expres-
sion of product rate in NESS, which has clear biophysical significance. Up till now,
it is a general belief that being an activator or an inhibitor is an intrinsic property
of the modifier. However, we reveal that this traditional point of view is based on
the equilibrium assumption. A modifier may no longer be an overall activator or
inhibitor when the reaction system is not in equilibrium. Based on the regulation
of enzyme activity by the modifier concentration, we classify the kinetic behavior
of the modifier into three categories, which are named hyperbolic behavior, bell-
shaped behavior, and switching behavior, respectively. We show that the switching
phenomenon, in which a modifier may convert between an activator and an inhibitor
when the modifier concentration varies, occurs only in NESS. Effects of drugs on the
Pgp ATPase activity, where drugs may convert from activators to inhibitors with the
increase of the drug concentration, are taken as a typical example to demonstrate
the occurrence of the switching phenomenon.
Keywords: inhibitor, effector, NESS, net flux, switching behavior
1 Introduction
Modifiers or effectors, ligands that bind to enzymes and thereby alter their catalytic
activity, play a crucial role in the study of biochemical problems, e.g., enzymatic catalysis
and metabolic pathways [1–5]. Moreover, they have wide applications in pharmacology,
toxicology, industry and agriculture. Activators and inhibitors are defined as modifiers
that strengthen or weaken, respectively, the enzyme activity of the reaction system [6, 7].
The enzyme activity is generally characterized in terms of the rate of product formation
of the enzyme-catalyzed reaction in the steady state.
Most enzyme mechanisms that involve a modifier reversibly acting on Michaelis-
type enzymes can be regarded as a particular case of the general modifier mechanism of
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Botts and Morales, as is depicted in Fig. 1 [8]. Many theoretical biologists have studied
the steady state and transient phase kinetics of the general modifier mechanism [6–16]
and its particular cases, in which modifiers act on Michaelis-type enzymes as competitive
inhibitors, uncompetitive inhibitors or pure non-competitive inhibitors [1, 17–19].
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Figure 1:
Segel and Martin [6, 9] reported a steady state rate equation that is second degree
in both substrate concentration [S] and modifier concentration [R]. They also found
several conditions under which the rate equation can be reduced to one that is first
degree in [S] and in [R]. Fontes et al. [7] discussed the behavior of the modifier with the
change of substrate concentration [S] under the assumption of rapid equilibrium. Laidler
[19] studied the behavior of the modifier with the change of modifier concentration
[R] under some simplifying assumptions. He also suggested definitions of competitive,
uncompetitive and noncompetitive activation, by analogy with the generally accepted
definitions for inhibition.
The major differences among the contributions of these authors are the set of
simplifying assumptions made about the steady state reached by the enzyme-catalyzed
reaction system [20]. However, to date, there is still a lack of a complete analysis about
the steady state kinetics of the general modifier mechanism of Botts and Morales without
any simplifying assumptions. The major difficulty lies in the fact that the traditional
approaches in solving this problem obscure the essence, which can hardly be realized
without the concept of the net flux introduced in this article, of the enzyme system to
some extent.
It is illuminating to point out that the modifier- and substrate-binding steps are not
dead-end reactions in the enzyme system, and so they are not necessarily in equilibrium
[1]. We have good reasons to believe that biochemical systems in living cells generally
operate in a state far from equilibrium. Whether the cyclic reaction mechanism in Fig.1
satisfies the equilibrium assumption, i.e. detailed balance, depends on whether the
system is closed or open. A closed system will finally approach an equilibrium steady
state, whereas an open system, driven by an external source of energy, tend to reach a
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non-equilibrium steady state (NESS) [21–24].
In this article, we remove the equilibrium assumption and provide a general analysis
of the kinetic behavior of the modifier in NESS. Enlightened by the circulation theory of
Markov chains [25], we introduce the net flux into discussion and acquire an expression
of product rate in NESS, which has clear biophysical significance. The essence of the
general modifier kinetics is then revealed to be the competition between the equilibrium
and non-equilibrium effects.
So far, it is a general belief that a modifier acts as either an activator or an inhibitor
for all its possible concentration values [R] when the substrate concentration [S] is fixed.
However, we find that a modifier cannot be regarded as an overall activator or inhibitor
when the reaction system is in NESS. According to our results, a particular modifier
may convert from an activator to an inhibitor or vice versa with the change of [R].
More specifically, we classify the kinetic behavior of the modifier into three categories,
which are named hyperbolic behavior, bell-shaped behavior, and switching behavior,
respectively. The latter two kinds of behavior will never occur in an equilibrium steady
state.
Incidentally, drugs are typical modifiers in pharmacology. The presence of the drug
can activate or inhibit the enzyme activity. Experimental data show that a drug can
always act as an activator regardless of its concentration, or first act as an activator then,
from a certain concentration value, transit to be an inhibitor [16]. Here the occurrence
of switching phenomenon provides strong support for the argument presented in this
paper.
2 Methods
2.1 Catalytic cycle
In this article, the symbols E, S, R and P stand for the enzyme molecule, the
substrate molecule, the modifier molecule, and the product molecule, respectively, while
the composite symbols ES, ER and ERS represent the corresponding complexes. If
there is only one enzyme molecule, it may convert among four states: the free (unbound)
enzyme E, the complex ES, the complex ERS and the complex ER. Then from the
perspective of the single enzyme molecule, the kinetics are stochastic and cyclic, as is
shown in Fig. 2, with pseudo-first-order rate constants a1[S], a2[R], a3[S], and a4[R],
and first-order rate constants b1 = b
′
1 + c1, b2, b3 = b
′
3 + c3, and b4. We add the rate
constants b′1 and c1, since there are two ways of transition from the complex ES to the
free enzyme E. The rate constants b′3 and c3 are added for the same reason.
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Figure 2:
2.2 Net flux
Based on the law of mass action, we have the following kinetics equations:


d[E]
dt
= −(a1[S] + a4[R])[E] + b1[ES] + b4[ER],
d[ES]
dt
= a1[S][E] − (b1 + a2[R])[ES] + b2[ERS],
d[ERS]
dt
= a2[R][ES]− (b2 + b3)[ERS] + a3[S][ER],
d[E]
dt
= a4[R][E] + b3[ERS]− (b4 + a3[S])[ER],
(1)
where b1 = b
′
1 + c1, b3 = b
′
3+ c3. The above four equations constitute a system of linear
equations with coefficient matrix
Q =


−(a1[S] + a4[R]) b1 0 b4
a1[S] −(b1 + a2[R]) b2 0
0 a2[R] −(b2 + b3) a3[S]
a4[R] 0 b3 −(b4 + a3[S])


. (2)
Let E0 = [E] + [ES] + [ER] + [ERS] be the total enzyme concentration. Then the
quantities µE = [E]/E0, µES = [ES]/E0, µERS = [ERS]/E0, and µER = [ER]/E0
represent the probability distribution of the four enzyme states, respectively. The whole
setup is nothing but a continuous-time Markov chain with transition density matrix Qt
(the transpose of the matrix Q).
It should be indicated that the enzyme-modifier and enzyme-substrate interactions
often involve rapid binding steps followed by a slow conformational change or chemical
step [26]. Thus, the quasi-steady approximation can be applied based on the difference
in timescales between the catalytic cycle kinetics and the overall rate of change of bio-
chemical reactions [27]. Assuming that the cycle kinetics represented in Fig. 2 are rapid
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and maintain the enzyme and the complexes in a rapid quasi-steady state, we can obtain
the steady state rate, v, of product formation for the general modifier kinetics:
v =
d[P ]
dt
= c1[ES] + c3[ERS] = E0(c1µES + c3µERS). (3)
For simplicity, we normalize the product rate v and write
v = c1µES + c3µERS (4)
hereinafter.
In order to obtain the steady state concentrations [E], [ES], [ER], and [ERS], we
set d[E]/dt = d[ES]/dt = d[ERS]/dt = d[ER]/dt = 0. Then Eq. (1) reduces to the
following compact form:
Qµ = 0, (5)
where µ = (µE , µES, µERS , µER)
t is a column vector representing the steady state prob-
ability distribution of the four enzyme states.
In the spirit of the circulation theory of Markov chains [25], we introduce the
net fluxes, namely the differences between fluxes in clockwise direction and fluxes in
counter-clockwise direction along adjacent states of the catalytic cycle depicted in Fig. 2.
When the reaction system reaches a steady state, the net fluxes between all adjacent
states along the catalytic cycle are identical. Denote by J the net flux along the cycle
E → ES → ERS → ER → E. With the net flux J introduced above, Eq. (5) can be
simplified to the following circulation equations:


J = a1[S]µE − b1µES,
J = a2[R]µES − b2µERS ,
J = b3µERS − a3[S]µER,
J = b4µER − a4[R]µE .
(6)
2.3 Equilibrium and non-equilibrium steady states
From the perspective of a single enzyme molecule, the enzyme system depicted in
Fig. 1 is in detailed balance if the net flux J along the catalytic cycle depicted in Fig. 2
is zero, i.e. 

a1[S]µE = b1µES,
a2[R]µES = b2µERS ,
b3µERS = a3[S]µER,
b4µER = a4[R]µE .
(7)
In this article, a steady state that satisfy the condition of detailed balance described
in Eq.(7) is referred to as an equilibrium steady state. Unless otherwise stated, the
5
word ‘equilibrium’ appearing in this article will be always understood as an equilibrium
steady state. However, if detailed balance is violated, then the enzyme system depicted
in Fig. 1 is an open system that approaches a non-equilibrium steady state (NESS)
[23, 24]. This is the scenario in enzyme kinetics [6, 28].
2.4 Steady state rate formula
In the two extreme cases when the modifier concentration approaches zero or in-
finity, the general modifier mechanism reduces to the single-substrate single-product
Michaelis-Menten mechanism depicted in Fig. 3. The steady state product rate can be
easily calculated in such cases. In fact, when the modifier concentration [R] is zero, the
steady state rate is
v0 = c1µES =
c1a1[S]
a1[S] + b1
. (8)
Similarly, when the modifier concentration [R] is very large, the steady state rate is
v∞ = c3µERS =
c3a3[S]
a3[S] + b3
. (9)
The steady state rates v0 and v∞ are collectively referred to as limiting product rates
hereinafter.
ES + ES
+ERS ERS
PE+
PER+
a1 c1
c3
b1
a3
b3
’
’
Figure 3:
Let ν = µER + µERS be the sum of the steady state probabilities of enzyme states
ER and ERS. It follows from the definition of product rate (4), the circulation equation
(6), and the expressions of two limiting product rates (8) and (9) that
v − v0 = (v∞ − v0)ν + (
v∞
a3
−
v0
a1
)
J
[S]
. (10)
The quantity
∆v = v − v0 (11)
in the left-hand side of Eq. (10) is of special significance, since the sign of ∆v reflects the
role of the modifier. A positive sign of ∆v indicates that the modifier is an activator,
while a negative sign of ∆v indicates that the modifier is an inhibitor.
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It is important to notice that the steady state rate formula (10) has clear biophys-
ical significance. It is easy to see from this expression that the role of the modifier is
determined by the competition of the first term of the right-hand side which does not
include the net flux J and the second term which includes the net flux J .
3 Kinetic analysis
3.1 Kinetic analysis in an equilibrium steady state
In an equilibrium steady state, the catalytic cycle in Fig. 2 is in detailed balance
and there is no net flux. In this case, the steady state rate formula (10) suggests that
v = v0 + (v∞ − v0)ν. (12)
Based on the condition of detailed balance (7), we have the following equation in which
the dependence of the steady state rate v on the modifier concentration [R] becomes
extremely clear:
v =
v∞[R] + v0K
[R] +K
, (13)
where K = (b1b2a3 + a1b2a3[S])/(a1a2b3 + a1a2a3[S]) is a constant if the substrate
concentration [S] is fixed.
Notice that if [S] is fixed, the product rate in equilibrium exhibits a hyperbolic
dependence on [R]. In this case, the modifier acts as an overall activator or inhibitor
for all its possible concentration values, depending on whether v0 is smaller or greater
than v∞. In other words, when the reaction system is in an equilibrium steady state,
to be an activator or an inhibitor is an intrinsic property of the modifier. Fig. 4 is an
illustration of the above conclusion.
3.2 Kinetic analysis in NESS
In a non-equilibrium steady state, the net flux J will no longer vanish. As is
mentioned above, the steady state rate formula (10) has clear biophysical significance
and the role of the modifier is determined by the competition of the equilibrium term
veq = (v∞ − v0)ν (14)
which reflects the contribution of the equilibrium kinetics and the non-equilibrium term
vneq = (
v∞
a3
−
v0
a1
)
J
[S]
(15)
which reflects the contribution of the non-equilibrium kinetics due to the non-zero net
flux J .
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In the following discussion, for simplicity, we assume v∞ < v0. The other case of
v∞ > v0 can be discussed in the same way. Under this assumption, the equilibrium term
veq is negative for all possible values of [R]. It is readily verified that the equilibrium
term veq, which behaves like the product rate in an equilibrium steady state, exhibits an
approximately hyperbolic dependence on [R], as is illustrated by the red curve in Fig. 5.
On the other hand, the expression of J in the supplementary material indicates that the
non-equilibrium term vneq exhibits a bell shape vanishing at both zero and infinity as a
function of [R], as is illustrated by the green curve in Fig. 5.
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Under certain conditions described in the next section (Sec. 4.4), the non-equilibrium
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term vneq may be positive and play a dominating role compared to the negative con-
tribution of the equilibrium term veq, as is illustrated in Fig. 5. In this case, v − v0 is
positive when [R] is small and negative when [R] is sufficiently large. The quantity ∆v
will change the sign somewhere in the range of the modifier concentration [R]. In other
words, the role played by the modifier will convert from an activator to an inhibitor, as
is illustrated by the blue curve in Fig. 5.
Unexpectedly, the traditional point of view that being an activator or an inhibitor
is an intrinsic property of the modifier does not hold in NESS. The role of the modifier
depends greatly on the modifier concentration [R]. The new phenomenon in NESS
described above, in which the role of the modifier converts between an activator and an
inhibitor, is referred to as switching phenomenon throughout this paper. We will discuss
the switching behavior of the modifier in much more detail in Sec. 4.4.
Before leaving this section, we would like to point out that the switching behavior of
the modifier may provide an explanation for the phenomenon of the side-effects caused by
excessive intake of drugs. In fact, drugs are typical modifiers in pharmacology. If a drug
operates in a mechanism discussed in this article that is far from equilibrium, the above
analysis predicts that the role of the drug may convert when the drug concentration
varies. Specifically, when a switching modifier is a drug designed to inhibit a particular
enzyme in vitro, the concentration of the drug must be controlled within a certain range
to maintain the inhibition effect. An exceptionally high concentration may cause the
dangerous side-effects in which the inhibitor can produce an activation effect.
4 Classification of the Modifier
4.1 Preparations
We are now prepared to classify all possible steady state behavior of modifiers
involved in the general modifier mechanism of Botts and Morales depicted in Fig. 1. We
will give a quantitative criterion for various kinds of non-equilibrium kinetics in terms
of the rate constants, ai and bi, and the limiting product rates, v0 and v∞. To make our
discussion friendly to those unfamiliar with tedious mathematical tools, we would like
to present the results here and put the mathematical treatment in the supplementary
material.
The following three quantities play a key role in our classification:
∆1 = v∞ − v0,
∆2 = q
′(v∞ − v0) + k(
v∞
a3
−
v0
a1
),
∆3 = (q − q
′)(v∞ − v0)− k(
v∞
a3
−
v0
a1
),
(16)
where k = a1a2b3b4 − b1b2a3a4 and q, q
′ (q′ < q) are positive parameters depending on
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the rate constants and the substrate concentration [S].
Virtually, in terms of the sign of the above three discriminants, we can classify the
behavior of the modifier with completeness and clarity.
4.2 Hyperbolic behavior: ∆2∆3 > 0
If ∆2∆3 > 0, the steady state product rate exhibits an approximately hyperbolic
dependence on [R]. In this case, the modifier behaves in the same way as it does in an
equilibrium steady state except that the modification is stronger or weaker due to the
contribution of the net flux J . The blue curves in Fig. 6(A) and Fig. 6(B) illustrate
the hyperbolic behavior of the modifier as an overall activator and an overall inhibitor,
respectively.
4.3 Bell-shaped behavior: ∆1∆3 < 0
If ∆1∆3 < 0, the steady state product rate exhibits a bell-shaped dependence on
[R]. The bell-shaped behavior differs from the hyperbolic behavior in that the product
rate will reach an extreme value which excels the limiting rate v∞ with the increase of
[R]. The red curves in Fig. 6(A) and Fig. 6(B) illustrate the bell-shaped behavior of the
modifier as an overall activator and an overall inhibitor, respectively.
Although both the hyperbolic-behaved and bell-shaped-behaved modifiers are over-
all activators or inhibitors for all possible values of [R] when [S] is fixed, there exist cru-
cial differences between them. For the hyperbolic kinetics, an inordinately large increase
of [R] is necessary to bring about even a comparatively modest change in the enzyme
activity. For the bell-shaped kinetics, on the contrary, a modest increase of [R] will make
the enzyme activity exceed its limit value v∞. Therefore, if the requirement for effec-
tive regulation (activation or inhibition) of the living body is needed, then bell-shaped
modification will be a good choice.
4.4 Switching behavior: ∆1∆2 < 0
If ∆1∆2 < 0, the quantity ∆v will change the sign somewhere in the range of the
modifier concentration. In this case, the role played by the modifier will convert from an
activator to an inhibitor or vice versa. Therefore in NESS, as is pointed out in Sec. 3.2,
the effect of activation or inhibition should not be viewed as an intrinsic property of the
modifier.
The switching behavior of the modifier is illustrated by the green curves in Fig. 6(A)
and Fig. 6(B). Fig. 6(A) illustrates the transition from an inhibitor to an activator, while
Fig. 6(B) illustrates the transition from an activator to an inhibitor.
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4.5 Classification of the modifier in terms of [S]
Incidentally, the behavior of the modifier can be classified according to the regula-
tion of enzyme activity by the substrate concentration [S]. In fact, the steady state rate
v may exhibit an approximately hyperbolic or a bell-shaped dependence on [S]. The
bell-shaped dependence differs from the hyperbolic one in that the steady state rate will
reach an extreme value which excels the saturated rate with the increase of [S]. This
conclusion is illustrated in Fig. 7, where the blue and red curves represent the above
two cases, respectively.
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5 Discussion
5.1 Conditions for hyperbolic behavior
In the following discussion, the bell-shaped behavior and the switching behavior
of the modifier are collectively referred to as non-hyperbolic behavior. As is analyzed
above, non-hyperbolic behavior never appears in an equilibrium steady state. In this
section, we will discuss another case in which non-hyperbolic behavior never occurs.
To this end, we rewrite the steady state rate formula (10) as
∆v = (v∞ − v0)(ν +
J
a3[S]
) +
v0
[S]
(
1
a3
−
1
a1
)J. (17)
It is readily verified that the first term on the right-hand side of this equation exhibits a
hyperbolic dependence on [R]. Hence non-hyperbolic behavior will never occur as long
as the second term vanishes.
In an equilibrium steady state, the second term vanishes due to the zero net flux.
Another crucial situation where the second term will vanish arises when a1 = a3, which
implies that whether the modifier is bound to the enzyme or not will not affect the
binding affinity of the substrate binding site. The above argument leads to the fact
that when the binding rate of the substrate is irrelevant of the modifier, only hyperbolic
behavior will occur, even if the enzyme system is in NESS.
5.2 Examples of switching behavior
As is pointed out in the last paragraph of Sec. 3.2, drugs are typical modifiers in
pharmacology. If a drug operates in a mechanism discussed in this article that is far
from equilibrium, the above analysis predicts that the role of the drug may convert when
the drug concentration varies.
ATPase activity associated with P-glycoprotein (Pgp) is characterized by three
drug-dependent phases: basal (no drug), drug-activated, and drug-inhibited. The com-
munication between the drug-binding site and the ATP hydrolytic site on a Pgp enzyme
makes the reaction system a general modifier mechanism of Botts and Morales where
ATP acts as the substrate and the drug acts as the modifier [16, 29].
Experimental data show that both hyperbolic activation and switching phenomena
occur under the experimental condition of pH 7.4 and 37◦C. The four curves in Fig. 8,
which was first generated by Al-Shawi et al. [16, 30], represent the variation trends of
enzyme activity versus concentrations of different types of drugs, namely valinomycin,
verapamil, SL-verapamil, and colchicine, respectively. The occurrence of switching phe-
nomenon in this experiment strongly supports the analysis of non-equilibrium kinetics
of the general modifier mechanism presented in this paper.
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Figure 8:
5.3 Applications
We have seen that the core of the general modifier mechanism of Botts and Morales
is the four-state cyclic reaction system depicted in Fig. 2. Actually, the four-state
cyclic topology is fundamental, since it models almost all possible reaction mechanism
of proteins with two binding sides. Particularly, in living cells, biochemical processes
that involve a four-state cyclic reaction system are very common. For example, the
fundamental phosphorylation-dephosphorylation cycle illustrated in Fig. 9 constitutes a
four-state cyclic reaction system [27].
S KS
S*P S*
1
b4
b1
b3
b2
a [ATP]
3a
2a4a [PI] [ADP]
Figure 9:
Furthermore, in many biochemical reaction systems, proteins possess three or more
binding sides. An eight-state cubic reaction mechanism is proposed to describe such
kind of systems. A typical example of the eight-state cubic topology is the subunit of
the inositol 1,4,5-trisphosphate receptor (IP3R) which is a channel located in the endo-
plasmic reticulum that releases Ca2+ ions. Structurally, the IP3R is a large homomeric
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tetramer of four subunits forming a single ion-conducting channel [31]. The gating of
IP3R channels requires that three or all of the four subunits are at the open state [32].
Each subunit has one binding site for IP3 and two binding sites for Ca
2+. Thus there
are eight possible states for the subunit, which is illustrated in Fig. 10. Binding with
IP3 ‘potentiates’ the subunit. The two calcium binding sites activate and inactivate the
subunit, and a subunit is activated when IP3 and the activating calcium site are bound
but the inactivating site is unbound [33].
Activating Calcium
Inhibitory Calcium
IP3
1
2 3
4
5
6: open state 7
8
Figure 10:
Besides, a great number of proenzymes activation mechanisms have one or two,
identical or different modifiers acting on the activating and the activated enzymes. It
turns out that such activation mechanisms may be considered, really or formally, as
particular cases of the general eight-state cubic reaction mechanism [34].
Mathematically, it can be proved by the theory of Markov chains that if the binding
of one site is irrelevant to that of the other two sites, the eight-state cubic reaction
system depicted in Fig. 10 can be reduced to the ‘combination’ of a uni-unimolecular
reaction system and a four-state cyclic reaction system. Thus the four-state catalytic
cycle discussed in this article plays a basic role in analyzing the eight-state cubic reaction
systems.
6 Conclusion
In our present work, we introduce the net flux J and propose a method in dealing
with the cyclic reaction systems. Early approaches on the general modifier mechanism
[7, 19] always give so many unreadable expressions and complicated situations that the
hidden biophysical meanings are extremely hard to clarify. In this paper, however,
with the notion of the net flux, the expression of steady state product rate has clear
biophysical significance. We would like to emphasize that if the reaction kinetics is
not too complex, the approach adopted in this paper gains an advantage of being neat
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and concise over the traditional approaches, e.g., the King-Atman method [1, 27] and
numerical computation.
In addition, we would like to point out that the single-molecule enzyme kinetics
is now attracting broad scientific attention [35]. The general discussion in this article
is based on the four-state catalytic cycle depicted in Fig. 2. What we concentrate on
is the transition among various states of a single enzyme molecule. The mathematical
theory of non-equilibrium Markov chains and the concept of net flux along a cycle
render possible a deep understanding of a number of interesting phenomena that never
appear in equilibrium systems, such as the switching behavior of the modifier involved
in the general modifier mechanism of Botts and Morales. Surely, applications of the
non-equilibrium theory of Markov chains are not limited to the model discussed in this
paper. It is expected to become a fundamental and useful tool in studying the single-
molecule enzyme systems involved in signal transduction, gene regulation and synthetic
biology.
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Figure captions
Fig. 1. General modifier mechanism of Botts and Morales. The symbols E, S, R
and P stand for the enzyme molecule, the substrate molecule, the modifier molecule
and the product molecule, respectively, while the composite symbols ES, ER and ERS
represent the corresponding complexes. The symbols ai, b
′
i and ci are rate constants.
Fig. 2. Catalytic cycle of the general modifier mechanism depicted in Fig. 1. Since
both reaction rates b′1 and c1 (b
′
3 and c3) in Fig. 1 contribute to the transition from ES
(ERS) to E (ER), we use the symbol b1 (b3) to represent b
′
1 + c1 (b
′
3 + c3).
Fig. 3. Two extreme cases of the general modifier mechanism depicted in Fig. 1.
When the modifier concentration approaches zero or infinity, the general modifier mech-
anism reduces to the single-substrate single-product Michaelis-Menten mechanism de-
picted in this figure.
Fig. 4. Product rate (enzyme activity) in equilibrium versus modifier concentration.
The initial enzyme activity is scaled to 1=100%. In an equilibrium steady state, the
modifier acts as an overall activator (v∞ > v0) or inhibitor (v∞ < v0) for all possible
values of [R], as is shown by the blue and red curves, respectively. The rate constants
are chosen as a1 = 1, a2 = 2, b3 = 2, b4 = 1, b1 = 2, b2 = 1, a3 = 2, a4 = 1, c1 =
1.5, c3 = 1.5, [S] = 1 for the case of activation. The rate constants are chosen as
a1 = 1, a2 = 2, b3 = 2, b4 = 1, b1 = 2, b2 = 1, a3 = 2, a4 = 1, c1 = 1.5, c3 = 0.5, [S] = 1 for
the case of inhibition.
Fig. 5. The switching behavior of the modifier in NESS when v∞ < v0. The red and
green curves represent the equilibrium and non-equilibrium terms respectively and the
blue curve represents the quantity ∆v = v − v0. The rate constants are chosen as a1 =
1, a2 = 1, b3 = 1, b4 = 1, b1 = 0.2, b2 = 0.2, a3 = 0.1, a4 = 0.5, c1 = 1, c3 = 4.5833, [S] = 1
for this graph.
Fig. 6. Enzyme activity in NESS versus modifier concentration. (A) Enzyme
activity in NESS versus modifier concentration when v∞ > v0. The initial enzyme
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activity is scaled to 1=100%. The rate constants are chosen as a1 = 20, a2 = 20, b3 =
10, b4 = 10, b1 = 1, b2 = 1, a3 = 50, a4 = 10, c1 = 1, c3 = 2.3, [S] = 1 for the hyperbolic
behavior. The rate constants are chosen as a1 = 1, a2 = 10, b3 = 20, b4 = 30, b1 =
1, b2 = 1, a3 = 10, a4 = 1, c1 = 1, c3 = 21, [S] = 1 for the bell-shaped behavior. The rate
constants are chosen as a1 = 1, a2 = 10, b3 = 10, b4 = 10, b1 = 1, b2 = 1, a3 = 0.5, a4 =
1, c1 = 1, c3 = 3, [S] = 1 for the switching behavior. (B) Enzyme activity in NESS
versus modifier concentration when v∞ < v0. The rate constants are chosen as a1 =
10, a2 = 10, b3 = 10, b4 = 10, b1 = 1, b2 = 1, a3 = 10, a4 = 10, c1 = 1, c3 = 0.9, [S] = 1 for
the hyperbolic behavior. The rate constants are chosen as a1 = 1, a2 = 10, b3 = 50, b4 =
50, b1 = 1, b2 = 1, a3 = 20, a4 = 1, c1 = 1, c3 = 0.9, [S] = 1 for the bell-shaped behavior.
The rate constants are chosen as a1 = 1, a2 = 1, b3 = 1, b4 = 1, b1 = 0.2, b2 = 0.2, a3 =
0.1, a4 = 0.5, c1 = 1, c3 = 4.6, [S] = 1 for the switching behavior.
Fig. 7. Product rate (enzyme activity) in NESS versus substrate concentration.
The saturated enzyme activity is scaled to 1=100%. The blue and red curves represent
the hyperbolic and bell-shaped dependence, respectively. The rate constants are chosen
as a1 = 1, a2 = 1, b3 = 1, b4 = 1, b1 = 1, b2 = 1, a3 = 1, a4 = 2, c1 = 390, c3 = 10, [R] = 1
for the hyperbolic dependence. The rate constants are chosen as a1 = 1, a2 = 1, b3 =
1, b4 = 1, b1 = 0.2, b2 = 0.2, a3 = 0.1, a4 = 0.2, c1 = 1150, c3 = 10, [R] = 1 for the
bell-shaped dependence.
Fig. 8. Effects of drugs on Pgp ATPase activity. The ATPase activities of MDR1
reconstituted into mixed lipid vesicles were measured as a function of added drug concen-
tration at pH 7.4 and 37◦ C [16, 30]. black circles, valinomycin; inverted black triangles,
verapamil; gray diamonds, SL-verapamil; gray triangles, colchicine. Data for verapamil,
SL-verapamil, and colchicine are from Omote and Al-Shawi [30].
Fig. 9. A typical cellular biochemical switch consisting of a phosphorylation-
dephosphorylation cycle. The substrate molecule S may be a protein or other signaling
molecule. If S is a protein then the phosphorylation of S is catalyzed by a protein kinase
K and the dephosphorylation is catalyzed by a protein phosphatase P . The entire cycle
is accompanied by the reaction ATP ⇋ ADP+PI.
Fig. 10. Transition diagram for the eight-state subunit of IP3 receptor channel.
When the system is at state 6 (one IP3 and one activating Ca
2+ bound), the subunit is
activated.
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